On Thursday, Citi adjusted its outlook on Raymond James (NYSE:RJF), reducing the price target to $125 from $132 while maintaining a Neutral rating. The financial services company reported adjusted earnings per share (EPS) of $2.39, surpassing the estimates of $2.29 and the consensus of $2.31. This beat was attributed to a credit benefit from bank loans. However, net revenue fell short of expectations, totaling $3.23 billion compared to the anticipated $3.25 billion.
Raymond James's compensation expenses aligned with projections, but adjusted non-compensation expenses were reported at $494 million, which is lower than the estimated $495 million. The quarter's results were described as mixed, with a noted decline in brokerage and investment banking revenue, as well as net interest income (NII) and third-party fees due to decreased yields from third-party banks.
Management's comments during the earnings call suggested that Raymond James is positioned to navigate the current market competition effectively, especially with its sweep deposit rates. Despite this, Citi has revised its estimates downward to reflect the current business trends and reduced expectations for net interest income and third-party bank deposit revenues.
In other recent news, Raymond James Financial (NYSE:RJF), Inc. reported robust fiscal Q3 2024 results, with an 11% year-over-year surge in net revenues, reaching a record $3.23 billion. The company's net income available to common shareholders stood at $491 million, or $2.31 per diluted share. These results were propelled by a record number of financial advisors and client assets under administration, hitting a new high of $1.48 trillion.
JPMorgan recently adjusted its price target for Raymond James, setting it at $135.00, a slight decrease from the previous $137.00, while maintaining an Overweight rating on the stock. Despite the capital markets segment operating at a pre-tax loss, Raymond James' other business lines, such as the asset management and bank segments, reported strong pre-tax income.
Raymond James has also been active in share repurchases, buying back 2 million shares of common stock for $243 million. The company has expressed plans to continue these repurchases, focus on corporate development, and explore potential merger and acquisition opportunities.
Despite these recent developments, the company's total assets saw a 1% sequential decrease to $80.6 billion, and non-compensation expenses increased to support business growth.
InvestingPro Insights
As Raymond James (NYSE:RJF) navigates the competitive market landscape, recent data from InvestingPro provides a broader picture of the company's financial health and performance. With a market capitalization of $24.14B and a price-to-earnings (P/E) ratio of 13.73, Raymond James stands out for its consistency and profitability. Notably, the company has not only been profitable over the last twelve months but has also maintained dividend payments for an impressive 40 consecutive years, showcasing a stable financial track record.
InvestingPro Tips highlight that analysts have revised their earnings upwards for the upcoming period, reflecting optimism about the company's future performance despite the current challenges. Additionally, Raymond James's liquid assets exceed its short-term obligations, providing financial flexibility in uncertain times. For those interested in exploring more about Raymond's financial outlook, InvestingPro offers even more in-depth analysis and tips, which can be accessed with the coupon code PRONEWS24 for up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. With 5 additional InvestingPro Tips available, investors can gain a comprehensive understanding of the company's potential.
Overall, the combination of a solid dividend history, positive earnings revisions, and a strong liquidity position suggests that Raymond James is equipped to continue delivering value to its shareholders. As the financial sector faces headwinds, these metrics could be pivotal for investors making informed decisions regarding Raymond James's stock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.